$ICUI
ICU Medical Inc

2014 Q1 Form 10-Q Financial Statement

#000088398414000036 Filed on May 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $73.23M $74.30M
YoY Change -1.44% -1.61%
Cost Of Revenue $37.20M $37.51M
YoY Change -0.81% -7.5%
Gross Profit $36.03M $36.79M
YoY Change -2.08% 5.23%
Gross Profit Margin 49.2% 49.52%
Selling, General & Admin $22.52M $22.87M
YoY Change -1.52% 9.46%
% of Gross Profit 62.51% 62.15%
Research & Development $3.631M $1.903M
YoY Change 90.8% -29.34%
% of Gross Profit 10.08% 5.17%
Depreciation & Amortization $4.765M $4.712M
YoY Change 1.12% -1.36%
% of Gross Profit 13.23% 12.81%
Operating Expenses $26.15M $24.77M
YoY Change 5.58% 5.03%
Operating Profit $9.877M $12.03M
YoY Change -17.86% 5.65%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $210.0K $168.0K
YoY Change 25.0% 24.44%
Pretax Income $10.09M $12.19M
YoY Change -17.27% 5.87%
Income Tax $3.430M $3.508M
% Of Pretax Income 34.0% 28.77%
Net Earnings $6.657M $8.685M
YoY Change -23.35% 14.26%
Net Earnings / Revenue 9.09% 11.69%
Basic Earnings Per Share $0.44 $0.60
Diluted Earnings Per Share $0.43 $0.58
COMMON SHARES
Basic Shares Outstanding 15.10M shares 14.51M shares
Diluted Shares Outstanding 15.40M shares 15.05M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $303.8M $233.6M
YoY Change 30.05% 27.23%
Cash & Equivalents $227.6M $154.6M
Short-Term Investments $76.20M $78.90M
Other Short-Term Assets $12.50M $10.80M
YoY Change 15.74% 11.34%
Inventory $36.69M $36.54M
Prepaid Expenses
Receivables $43.32M $52.94M
Other Receivables $4.500M $300.0K
Total Short-Term Assets $400.7M $334.1M
YoY Change 19.93% 21.06%
LONG-TERM ASSETS
Property, Plant & Equipment $90.38M $86.99M
YoY Change 3.89% 4.58%
Goodwill $1.478M $1.478M
YoY Change 0.0% 0.0%
Intangibles $8.013M $9.647M
YoY Change -16.94% -12.82%
Long-Term Investments
YoY Change
Other Assets $5.800M $5.600M
YoY Change 3.57% 16.67%
Total Long-Term Assets $105.7M $103.8M
YoY Change 1.87% 3.25%
TOTAL ASSETS
Total Short-Term Assets $400.7M $334.1M
Total Long-Term Assets $105.7M $103.8M
Total Assets $506.4M $437.9M
YoY Change 15.65% 16.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.71M $11.04M
YoY Change 6.11% -6.64%
Accrued Expenses $13.79M $14.53M
YoY Change -5.09% 7.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.50M $25.57M
YoY Change -0.26% 0.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.700M $3.300M
YoY Change -18.18% -19.51%
Total Long-Term Liabilities $2.700M $3.300M
YoY Change -18.18% -19.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.50M $25.57M
Total Long-Term Liabilities $2.700M $3.300M
Total Liabilities $32.20M $34.40M
YoY Change -6.4% -6.01%
SHAREHOLDERS EQUITY
Retained Earnings $389.2M $350.8M
YoY Change 10.94% 13.73%
Common Stock $84.56M $67.22M
YoY Change 25.8% 12.8%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.706M $10.78M
YoY Change -84.17% -60.12%
Treasury Stock Shares 27.00K shares
Shareholders Equity $474.2M $403.5M
YoY Change
Total Liabilities & Shareholders Equity $506.4M $437.9M
YoY Change 15.65% 16.31%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $6.657M $8.685M
YoY Change -23.35% 14.26%
Depreciation, Depletion And Amortization $4.765M $4.712M
YoY Change 1.12% -1.36%
Cash From Operating Activities $12.71M $10.76M
YoY Change 18.12% -41.3%
INVESTING ACTIVITIES
Capital Expenditures $5.908M $5.831M
YoY Change 1.32% 60.55%
Acquisitions
YoY Change
Other Investing Activities -$6.000M -$800.0K
YoY Change 650.0% -20.0%
Cash From Investing Activities -$12.00M -$7.000M
YoY Change 71.36% 43.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.835M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $929.0K $5.205M
YoY Change -82.15% -37.97%
NET CHANGE
Cash From Operating Activities $12.71M $10.76M
Cash From Investing Activities -$12.00M -$7.000M
Cash From Financing Activities $929.0K $5.205M
Net Change In Cash $1.648M $8.969M
YoY Change -81.63% -58.93%
FREE CASH FLOW
Cash From Operating Activities $12.71M $10.76M
Capital Expenditures $5.908M $5.831M
Free Cash Flow $6.806M $4.933M
YoY Change 37.97% -66.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43323000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45318000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11335000 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11714000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15551000 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13787000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125140000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
129217000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2193000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2117000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83043000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
78495000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1207000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1208000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
142000 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
237000 shares
CY2014Q1 us-gaap Assets
Assets
506432000 USD
CY2013Q4 us-gaap Assets
Assets
499643000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
400733000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
394296000 USD
CY2014Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
76224000 USD
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
70869000 USD
CY2014Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1008000 USD
CY2013Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
196000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227623000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
226022000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146900000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154631000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7731000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1601000 USD
CY2014Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
303847000 USD
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
296891000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15103000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15202000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15102000 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15175000 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1510000 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
1520000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6581000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6315000 USD
CY2014Q1 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2013Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
37505000 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
37203000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4351000 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4371000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7518000 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5829000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3630000 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4011000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4712000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4765000 USD
CY2014Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"></font><font style="font-family:inherit;font-size:10pt;">In April 2014, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") number 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity. This ASU changes the criteria for reporting discontinued operations and adds additional disclosures on discontinued operations. ASU 2014-08 improves the definition of discontinued operations by limiting discontinued operations reporting to disposals of components of an entity that represent strategic shifts that have or will have a major effect on an entities operations and financial results. Under current U.S. GAAP, disposals of small groups of assets that are recurring in nature and do not change an entity's strategy currently qualify for discontinued operations. ASU 2014-08 is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2014. We do not anticipate a material impact on our consolidated financial statements from adoption of this ASU.</font></div></div>
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-47000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1238000 USD
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.34
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.29
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1034000 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1178000 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
1478000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
1478000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
36027000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
36794000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10087000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12193000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3508000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3430000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
382000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-244000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2416000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3981000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2949000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2557000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2267000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
578000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
800000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1234000 USD
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
546000 shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
298000 shares
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8013000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8490000 USD
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11116000 USD
CY2014Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
20722000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9835000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
34451000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
36687000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
21867000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2749000 USD
CY2014Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4849000 USD
CY2014Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
601000 USD
CY2013Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
675000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
506432000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
499643000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26886000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
25501000 USD
CY2013Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4402000 USD
CY2014Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
2713000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
929000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5205000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7000000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11995000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10764000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12714000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
210000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
168000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
26150000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
24769000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12025000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
9877000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2370000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-76000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-493000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-21000 USD
CY2013Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
126000 USD
CY2014Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
117000 USD
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2014Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5835000 USD
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
120000 USD
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
355000 USD
CY2014Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
36908000 USD
CY2013Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
19131000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5908000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5831000 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7319000 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8065000 USD
CY2013Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5966000 USD
CY2014Q1 us-gaap Prepaid Taxes
PrepaidTaxes
4440000 USD
CY2014Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30936000 USD
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18317000 USD
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2904000 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4202000 USD
CY2014Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1384000 USD
CY2013Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1267000 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
6657000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
8685000 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
219596000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
213001000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87861000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
90379000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-191000 USD
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1903000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3631000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
382576000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
389233000 USD
CY2014Q1 us-gaap Revenues
Revenues
73230000 USD
CY2013Q1 us-gaap Revenues
Revenues
74299000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
74173000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
73113000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22519000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22866000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1973000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1390000 USD
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
474207000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
464725000 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1000 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
27000 shares
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1706000 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
49000 USD
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15053000 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15395000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15097000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14507000 shares
CY2014Q1 icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2040
CY2014Q1 icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2014
CY2014Q1 icui Incometaxesincludingexcesstaxbenefitsanddeferredincometaxes
Incometaxesincludingexcesstaxbenefitsanddeferredincometaxes
1956000 USD
CY2013Q1 icui Incometaxesincludingexcesstaxbenefitsanddeferredincometaxes
Incometaxesincludingexcesstaxbenefitsanddeferredincometaxes
2017000 USD
CY2014Q1 icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
-410000 USD
CY2013Q1 icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
-6000 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000883984
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15209943 shares
CY2014Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE

Files In Submission

Name View Source Status
0000883984-14-000036-index-headers.html Edgar Link pending
0000883984-14-000036-index.html Edgar Link pending
0000883984-14-000036.txt Edgar Link pending
0000883984-14-000036-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
icui-20140331.xml Edgar Link completed
icui-20140331.xsd Edgar Link pending
icui-20140331_cal.xml Edgar Link unprocessable
icui-20140331_def.xml Edgar Link unprocessable
icui-20140331_lab.xml Edgar Link unprocessable
icui-20140331_pre.xml Edgar Link unprocessable
icui-ex311_20140331x10q.htm Edgar Link pending
icui-ex312_20140331x10xq.htm Edgar Link pending
icui-ex321_20140331x10xq.htm Edgar Link pending
icui03311410-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending